Platelet-rich plasma is a concentrate of platelet rich plasma protein derived from whole blood, centrifuged to remove red blood cells. To build up a plasma rich platelet arrangement, blood should first be drawn from a patient. The platelets are isolated from other platelets and their focus is expanded amid a procedure called centrifugation, after that the expanded centralization of platelets is consolidated with residual blood. Platelet rich plasma has a solid impact in the early period of mending. Moreover, platelet rich plasma is utilized for tendon and ligament wounds, knee osteoarthritis, degenerative knee ligament and incessant elbow necessities, muscle strain and tears. Expanding ceaseless ailment populace, expanding number patients enduring with orthopedic wounds, rising number of restorative surgeries, and expanding mindfulness about advantages related with platelet rich plasma are key components driving the development of this market.
How Big is The Global Platelet Rich Plasma Market?
The Global Platelet Rich Plasma Market is expected to be around US$ 700 Million by 2028 at a CAGR of 15% in the given forecast period.
The major driving factors of Global Platelet Rich Plasma Market are as follows:
The restraining factors of Global Platelet Rich Plasma Market are as follows:
The Global Platelet Rich Plasma Market is segmented on the lines of its type, origin, applications and regional. Based on type segmentation it covers Pure-Platelet Rich Plasma (P-PRP), Leukocyte-Platelet Rich Plasma (L-PRP), Pure-Platelet Rich Fibrin (P-PRF). Based on origin segmentation it covers autologous, homologous, allogeneic. Based on application segmentation it covers orthopedic surgery, cosmetic surgery, general surgery, and neurosurgery, other surgeries (Urological, Cardiothoracic, Periodontal and Oral and Maxillofacial). The Global Platelet Rich Plasma Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Platelet Rich Plasma Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Platelet Rich Plasma Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Platelet Rich Plasma Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Harvest Technologies Corporation, Arthrex, Inc., Zimmer Biomet, DePuySynthes, Inc., Stryker Corporation, AdiStem Ltd., ISTO Biologics, Cesca Therapeutics, Inc., Emcyte Corporation, Nuo Therapeutics, Exactech Inc., and Regen Lab SA. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Platelet Rich Plasma Market has been segmented as below:
By Type Analysis:
· Pure-PRP
· Leukocyte-rich-PRP
· Pure-PRF
By Origin Analysis:
· Autologous PRP
· Allogeneic PRP
· Homologous PRP
By Applications Analysis:
· Orthopedic Surgery
· Cosmetic Surgery
· General Surgery
· Neurosurgery
· Others
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Platelet Rich Plasma Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Platelet Rich Plasma Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Section 1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 3 Executive Summary
3.1 Global Platelet Rich Plasma: Market Snapshot
3.2 Global Market Share Analysis by Region, 2017
3.3 Global Platelet-Rich Plasma Market: Opportunity Map
Section 4 Market Overview
4.1 Product Overview
4.2 Global Platelet-Rich Plasma Market: Key Industry Developments
4.3 Global Platelet-Rich Plasma Market: Market Indicators
Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.2.1 Increasing incidence of orthopedic and sports injuries
5.2.2 Rising number of cosmetic surgical procedures
5.2.3 Technological advancements and regulatory approvals for new devices
5.2.4 Increasing popularity of PRP products and treatments
5.2.5 Growing awareness about Platelet-Rich Plasma therapies
5.3 Restraints
5.3.1 Standardization in quality of allergen extracts
5.3.2 Difficulty in quality control of test results
5.4 Opportunities
5.4.1 Ultrasound & Platelet Rich Plasma Therapy
5.4.2 Advances in Technology & Devices will open new avenues
5.5 Porters Analysis
5.6 Value Chain Analysis
5.7 Platelet-Rich Plasma Market Outlook
Section 6 Platelet-Rich Plasma Market Analysis, by Type
6.1 Key Findings
6.2 Introduction
6.3 Global Platelet-Rich Plasma Market Value Share Analysis, by Type
6.4 Platelet-Rich Plasma Market Forecast, by Type
6.5 Platelet-Rich Plasma Market Analysis, by Type
6.5.1 Pure-PRP
6.5.2 Leukocyte-rich-PRP
6.5.3 Pure-PRF
6.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Type
6.7 Key Trends
Section 7 Platelet-Rich Plasma Market Analysis, by Origin
7.1 Key Findings
7.2 Introduction
7.4 Platelet-Rich Plasma Market Forecast, by Origin
7.5 Platelet-Rich Plasma Market Analysis, by Origin
7.5.1 Autologous PRP
7.5.2 Allogeneic PRP
7.5.3 Homologous PRP
7.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Origin
7.7 Key Trends
Section 8 Platelet-Rich Plasma Market Analysis, by Applications
8.1 Key Findings
8.2 Introduction
8.3 Global Platelet-Rich Plasma Market Value Share Analysis, by Applications
8.4 Platelet-Rich Plasma Market Forecast, by Applications
8.5 Platelet-Rich Plasma Market Analysis, by Applications
8.5.1 Orthopedic Surgery
8.5.2 Cosmetic Surgery
8.5.3 General Surgery
8.5.4 Neurosurgery
8.5.5 Others
8.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Applications
Section 9 Platelet-Rich Plasma Market Analysis, by Region
9.1 Global Platelet-Rich Plasma Market Snapshot, by Country
9.2 Global Platelet-Rich Plasma Market Value Share Analysis, by Region
9.3 Platelet-Rich Plasma Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region
Section 10 North America Platelet-Rich Plasma Market Analysis
10.1 Key Findings
10.2 Market Overview
10.3 Market Analysis, by Country
10.3.1 North America Market Value Share Analysis, by Country
10.3.2 North America Market Forecast by Country
10.4 Market Analysis, by Type
10.4.1 North America Market Value Share Analysis, by Type
10.4.2 North America Market Forecast, by Type
10.5 Market Analysis, by Origin
10.5.1 North America Market Value Share Analysis, by Origin
10.5.2 North America Market Forecast, by Origin
10.6 Market Analysis, by Applications
10.6.1 North America Market Value Share Analysis, by Applications
10.6.2 North America Market Forecast, by Applications
10.7 North America Market Attractiveness Analysis
10.7.1 By Type
10.7.2 By Origin
10.7.3 By Applications
10.8 Market Trends
Section 11 Europe Platelet-Rich Plasma Market Analysis
11.1 Key Findings
11.2 Market Overview
11.3 Market Analysis, by Country
11.3.1 Europe Market Value Share Analysis, by Country
11.3.2 Europe Market Forecast by Country
11.4 Market Analysis, by Type
11.4.1 Europe Market Value Share Analysis, by Type
11.4.2 Europe Market Forecast, by Type
11.5 Market Analysis, by Origin
11.5.1 Europe Market Value Share Analysis, by Origin
11.5.2 Europe Market Forecast, by Origin
11.6 Market Analysis, by Applications
11.6.1 Europe Market Value Share Analysis, by Applications
11.6.2 Europe Market Forecast, by Applications
11.7 Europe Market Attractiveness Analysis
11.7.1 By Type
11.7.2 By Origin
11.7.3 By Applications
11.8 Market Trends
Section 12 Asia Pacific Platelet-Rich Plasma Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Market Analysis, by Country
12.3.1 Asia Pacific Market Value Share Analysis, by Country
12.3.2 Asia Pacific Market Forecast by Country
12.4 Market Analysis, by Type
12.4.1 Asia Pacific Market Value Share Analysis, by Type
12.4.2 Asia Pacific Market Forecast, by Type
12.5 Market Analysis, by Origin
12.5.1 Asia Pacific Market Value Share Analysis, by Origin
12.5.2 Asia Pacific Market Forecast, by Origin
12.6 Market Analysis, by Applications
12.6.1 Asia Pacific Market Value Share Analysis, by Applications
12.6.2 Asia Pacific Market Forecast, by Applications
12.7 Asia Pacific Market Attractiveness Analysis
12.7.1 By Type
12.7.2 By Origin
12.7.3 By Applications
12.8 Market Trends
Section 13 Latin America Platelet-Rich Plasma Market Analysis
13.1 Key Findings
13.2 Market Overview
13.3 Market Analysis, by Country
13.3.1 Latin America Market Value Share Analysis, by Country
13.3.2 Latin America Market Forecast by Country
13.4 Market Analysis, by Type
13.4.1 Latin America Market Value Share Analysis, by Type
13.4.2 Latin America Market Forecast, by Type
13.5 Market Analysis, by Origin
13.5.1 Latin America Market Value Share Analysis, by Origin
13.5.2 Latin America Market Forecast, by Origin
13.6 Market Analysis, by Applications
13.6.1 Latin America Market Value Share Analysis, by Applications
13.6.2 Latin America Market Forecast, by Applications
13.7 Latin America Market Attractiveness Analysis
13.7.1 By Type
13.7.2 By Origin
13.7.3 By Applications
13.8 Market Trends
Section 14 MEA Platelet-Rich Plasma Market Analysis
14.1 Key Findings
14.2 Market Overview
14.3 Market Analysis, by Country
14.3.1 MEA Market Value Share Analysis, by Country
14.3.2 MEA Market Forecast by Country
14.4 Market Analysis, by Type
14.4.1 MEA Market Value Share Analysis, by Type
14.4.2 MEA Market Forecast, by Type
14.5 Market Analysis, by Origin
14.5.1 MEA Market Value Share Analysis, by Origin
14.5.2 MEA Market Forecast, by Origin
14.6 Market Analysis, by Applications
14.6.1 MEA Market Value Share Analysis, by Applications
14.6.2 MEA Market Forecast, by Applications
14.7 MEA Market Attractiveness Analysis
14.7.1 By Type
14.7.2 By Origin
14.7.3 By Applications
14.8 Market Trends
Section 15 Company Profiles
15.1 Global Platelet-Rich Plasma Market Share Analysis, by Company (2015)
15.2 Competition Matrix
15.3 Company Profiles
15.3.1 Harvest Technologies Corporation
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.1.2 Financial Overview
15.3.1.3 Product Portfolio
15.3.1.4 SWOT Analysis
15.3.1.5 Strategic Overview
15.3.2 Arthrex, Inc.
15.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.2.2 Financial Overview
15.3.2.3 Product Portfolio
15.3.2.4 SWOT Analysis
15.3.2.5 Strategic Overview
15.3.3 Zimmer Biomet
15.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.3.2 Financial Overview
15.3.3.3 Product Portfolio
15.3.3.4 SWOT Analysis
15.3.3.5 Strategic Overview
15.3.4 DePuy Synthes, Inc.
15.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.4.2 Financial Overview
15.3.4.3 Product Portfolio
15.3.4.4 SWOT Analysis
15.3.4.5 Strategic Overview
15.3.5 Stryker Corporation
15.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.5.2 Financial Overview
15.3.5.3 Product Portfolio
15.3.5.4 SWOT Analysis
15.3.5.5 Strategic Overview
15.3.6 AdiStem Ltd.
15.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.6.2 Financial Overview
15.3.6.3 Product Portfolio
15.3.6.4 SWOT Analysis
15.3.6.5 Strategic Overview
15.3.7 ISTO Biologics
15.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.7.2 Financial Overview
15.3.7.3 Product Portfolio
15.3.7.4 SWOT Analysis
15.3.7.5 Strategic Overview
15.3.8 Cesca Therapeutics, Inc.
15.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.8.2 Financial Overview
15.3.8.3 Product Portfolio
15.3.8.4 SWOT Analysis
15.3.8.5 Strategic Overview
15.3.9 Emcyte Corporation
15.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.9.2 Financial Overview
15.3.9.3 Product Portfolio
15.3.9.4 SWOT Analysis
15.3.9.5 Strategic Overview
15.3.10 Nuo Therapeutics
15.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.10.2 Financial Overview
15.3.10.3 Product Portfolio
15.3.10.4 SWOT Analysis
15.3.10.5 Strategic Overview
15.3.11 Exactech Inc.
15.3.11.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.11.2 Financial Overview
15.3.11.3 Product Portfolio
15.3.11.4 SWOT Analysis
15.3.11.5 Strategic Overview
15.3.12 Regen Lab SA
15.3.12.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.3.12.2 Financial Overview
15.3.12.3 Product Portfolio
15.3.12.4 SWOT Analysis
15.3.12.5 Strategic Overview
The Global Platelet Rich Plasma Market has been segmented as below:
By Type Analysis:
· Pure-PRP
· Leukocyte-rich-PRP
· Pure-PRF
By Origin Analysis:
· Autologous PRP
· Allogeneic PRP
· Homologous PRP
By Applications Analysis:
· Orthopedic Surgery
· Cosmetic Surgery
· General Surgery
· Neurosurgery
· Others
By Regional Analysis:
